Top Markets
Coin of the day
Cortexyme, Inc. Cortexyme, Inc.

Cortexyme, Inc.

CRTX
株式のランク #25185
Cortexyme, Inc. is a clinical-stage biopharmaceutical firm committed to... Cortexyme, Inc. is a clinical-stage biopharmaceutical firm committed to pioneering new therapies for Alzheimer's and various other degenerative conditions. The company's primary investigational drug, atuzaginstat (also known as COR388), is an orally delivered, small molecule inhibitor engineered to cross the blood-brain barrier and target gingipain. This compound is currently in Phase II/III clinical trials, where it is being assessed for its potential use in individuals with mild to moderate Alzheimer's disease, as well as for tackling oral squamous cell carcinoma, periodontitis, and coronavirus infections. Established in 2012, Cortexyme, Inc. is headquartered in South San Francisco, California.
株価
$1.95
最終同期: 2022-07-29
時価総額
$52.48M
変化(1日)
2.63%
変化(1年)
0.00%
US
取引 Cortexyme, Inc. (CRTX)

カテゴリー

Cortexyme, Inc.(CRTX)の株価履歴
終値の最高値: $2.18 (2022-07-01)

終値の最安値: $26.37 (2019-05-01)
Cortexyme, Inc. の株価履歴(2019 ~ 2026)
年間株価パフォーマンス
パフォーマンス
2022 -82.87%
2021 -62.60%
2020 -23.16%
2019 0.00%
類似企業または競合の株価
企業 株価 変化率 1年%
$539.14 35.65%
US
$1.04K 56.21%
NL
$118.70 -18.24%
AU
$760.57 8.46%
CH
$130.43 397.46%
US